Mining of Serum Glycoproteins by an Indirect Approach Using Cell Line Secretome

다국어 초록 (Multilingual Abstract)

Glycosylation is the most important and abundant post-translational modification in serum proteome. Several specific types of glycan epitopes have been shown to be associated with various types of disease. Direct analysis of serum glycoproteins is challenging due to its wide dy-namic range. Alternatively, glycoproteins can be disco-vered in the secretome of model cell lines and then con-firmed in blood. However, there has been little experi-men-tal evidence showing cell line secretome as a tractable target for the study of serum glycoproteins. We used a hydrazine-based glycocapture method to selectively enrich glycoproteins from the secretome of the breast cancer cell line Hs578T. A total of 132 glycoproteins were identified by nanoLC-MS/MS analysis. Among the identified proteins, we selected 13 proteins that had one or more N-gly-cosylation motifs in the matched peptides, which were included in the Secreted Protein Database but not yet in the Plasma Proteome Database (PPD), and whose antibod-ies were commercially available. Nine out of the 13 se-lected proteins were detected from human blood plasma by western analysis. Furthermore, eight proteins were also detected from the plasma by targeted LC-MS/MS, which had never been previously identified by data-dependent LC-MS/MS. Our results provide novel proteins that should be enrolled in PPD and suggest that analysis of cell line secretome with subfractionation is an efficient strategy for discovering disease-relevant serum proteins.

참고문헌 (Reference)

1 Touab, M., "Versican is differentially expressed in human melanoma and may play a role in tumor development" 160 : 549-557, 2002

2 Hakomori, S., "Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anti-cancer vaccines" 491 : 369-402, 2001

3 Meijer, D., "TSC22D1 and PSAP predict clinical outcome of tamoxifen treatment in patients with recurrent breast cancer" 113 : 253-260, 2009

4 Bause, E., "Structural requirements of N-glycosylation of proteins. Studies with proline peptides as conformational probes" 209 : 331-336, 1983

5 Chen, Y., "SPD--a web-based secreted protein database" 33 : D169-D173, 2005

6 Guerrier, L., "Reduction of dynamic protein concentration range of biological extracts for the discovery of low-abundance proteins by means of hexapeptide ligand library" 3 : 883-890, 2008

7 Huang, L.J., "Proteomics-based identification of secreted protein dihydrodiol dehydrogenase as a novel serum markers of non-small cell lung cancer" 54 : 87-94, 2006

8 Blobel, G., "Protein targeting (Nobel lecture)" 1 : 86-102, 2000

9 Roth, J., "Protein N-glycosylation along the secretory pathway: relationship to organelle topography and function, protein quality control, and cell interactions" 102 : 285-303, 2002

10 Kim, Y.J., "Perspectives on the significance of altered glycosylation of glycoproteins in cancer" 14 : 569-576, 1997

11 Lawlor, K., "Pathway-based biomarker search by high-throughput proteomics profiling of secretomes" 8 : 1489-1503, 2009

12 Amin, S.A., "Paracrine-stimulated gene expression profile favors estradiol production in breast tumors" 253 : 44-55, 2006

13 Lee, H., "Optimization of reversedphase microcapillary liquid chromatography for quantitative proteomics" 803 : 101-110, 2004

14 Apweiler, R., "On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database" 1473 : 4-8, 1999

15 Tsukuba, T., "New functional aspects of cathepsin D and cathepsin E" 10 : 601-611, 2000

16 Ross, P.L., "Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents" 3 : 1154-1169, 2004

17 Hanash, S.M., "Mining the plasma proteome for cancer biomarkers" 452 : 571-579, 2008

18 Csiszar, K., "Lysyl oxidases: a novel multifunctional amine oxidase family" 70 : 1-32, 2001

19 Hiraiwa, M., "Isolation, characterization, and proteolysis of human prosaposin, the precursor of saposins (sphingolipid activator proteins)" 304 : 110-116, 1993

20 Oh, Y., "Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition" 268 : 14964-14971, 1993

21 Goulet, B., "Increased expression and activity of nuclear cathepsin L in cancer cells suggests a novel mechanism of cell transformation" 5 : 899-907, 2007

22 Goo, Y.A., "Identification of secreted glycoproteins of human prostate and bladder stromal cells by comparative quantitative proteomics" 69 : 49-61, 2009

23 Chang, J.W., "Identification of circulating endorepellin LG3 fragment:Potential use as a serological biomarker for breast cancer" 2 : 23-32, 2008

24 Kim, H.J., "Identification of S100A8 and S100A9 as serological markers for colorectal cancer" 8 : 1368-1379, 2009

25 Zhang, H., "Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry" 21 : 660-666, 2003

26 Liu, T., "Human plasma Nglycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry" 4 : 2070-2080, 2005

27 Zhang, H., "High throughput quantitative analysis of serum proteins using glycopeptide capture and liquid chromatography mass spectrometry" 4 : 144-155, 2005

28 Mann, M., "Functional and quantitative proteomics using SILAC" 7 : 952-958, 2006

29 Liotta, L.A., "Clinical proteomics: written in blood" 425 : 905-, 2003

30 States, D.J., "Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study" 24 : 333-338, 2006

31 Wu, C.C., "Cancer cell-secreted proteomes as a basis for searching potential tumor markers: naso pharyngeal carcinoma as a model" 5 : 3173-3182, 2005

32 Klee, E.W., "Bioinformatics methods for prioritizing serum biomarker candidates" 52 : 2162-2164, 2006

33 Siriwardana, G., "Autocrine/paracrine regulation of breast cancer cell proliferation by growth hormone releasing hormone via Ras, Raf, and mitogen-activated protein kinase" 20 : 2010-2019, 2006

34 Yi, E.C., "Approaching complete peroxisome characterization by gas-phase fractionation" 23 : 3205-3216, 2002

35 Keller, A., "A uniform proteomics MS/MS analysis platform utilizing open XML file formats" 1 : 17-, 2005